RTX-1738

N/A

Report date: 2024/08/26 11:07:01
NME

Base Information

Drug NameRTX-1738
Drug Alias Nameanalog to RAP-219RTX-1738
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-dependent calcium channel gamma-8 subunit antagonists
TargetsVoltage-dependent calcium channel gamma-8 subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRapport Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRapport Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A